The Patent Finder

Terms ending in 2028

Celeniv Pte. Ltd.

Every in-force patent on Celeniv Pte. Ltd.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,916,146Treatment of Inflammatory Diseases Using Placental Stem Cells
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 10,494,607CD34+,CD45- Placental Stem Cell-Enriched Cell Populations
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 9,339,520Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 9,216,200Tumor Suppression Using Human Placental Perfusate and Human Placenta-Derived Intermediate Natural Killer Cells
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 9,725,694Composition for Collecting and Preserving Placental Stem Cells and Methods of Using the Composition
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited